rxstat › Shortages › Naratriptan

Naratriptan shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Naratriptan has no current shortage reported in Canada. It has been in shortage before; the history is below.
Products affected
0 / 5
Reports on file
28

Reports by product

Resolved
TEVA-NARATRIPTAN
1MG · TABLET · TEVA CANADA LIMITED
DIN 02314290 · ended Apr 8, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-NARATRIPTAN
2.5MG · TABLET · TEVA CANADA LIMITED
DIN 02314304 · ended Apr 1, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ NARATRIPTAN
2.5MG · TABLET TABLET · SANDOZ CANADA INCORPORATED
DIN 02322323 · ended Jan 30, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ NARATRIPTAN
2.5MG · TABLET TABLET · SANDOZ CANADA INCORPORATED
DIN 02322323 · ended Sep 15, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-NARATRIPTAN
1MG · TABLET · TEVA CANADA LIMITED
DIN 02314290 · ended Nov 7, 2024 · Disruption of the manufacture of the drug.
Resolved
TEVA-NARATRIPTAN
1MG · TABLET · TEVA CANADA LIMITED
DIN 02314290 · ended Aug 31, 2023 · Disruption of the manufacture of the drug.
Resolved
SANDOZ NARATRIPTAN
2.5MG · TABLET TABLET · SANDOZ CANADA INCORPORATED
DIN 02322323 · ended Sep 11, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVA-NARATRIPTAN
2.5MG · TABLET · TEVA CANADA LIMITED
DIN 02314304 · ended Aug 17, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVA-NARATRIPTAN
2.5MG · TABLET · TEVA CANADA LIMITED
DIN 02314304 · ended Jul 5, 2023 · Disruption of the manufacture of the drug.
Resolved
SANDOZ NARATRIPTAN
2.5MG · TABLET TABLET · SANDOZ CANADA INCORPORATED
DIN 02322323 · ended Jun 5, 2023 · Requirements related to complying with good manufacturing practices.
Resolved
TEVA-NARATRIPTAN
2.5MG · TABLET · TEVA CANADA LIMITED
DIN 02314304 · ended Feb 14, 2023 · Disruption of the manufacture of the drug.
Discontinued
AMERGE
2.5MG · TABLET · GLAXOSMITHKLINE INC
DIN 02237821

Showing 12 of 28 reports. All reports are on file with Health Canada.

What's happening

There are no active shortage reports for Naratriptan. Health Canada has 28 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Naratriptan is classified under “ANTIMIGRAINE PREPARATIONS” (ATC N02CC).

Recent changes

Common questions

When will Naratriptan be back in stock in Canada?

Naratriptan has no active shortage; supply is normal per Health Canada reports.

Why is Naratriptan in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antimigraine preparations)

Partial shortageAlmotriptan1 of 10 reported products affected · est. return Jan 23, 2026Partial shortageEletriptan1 of 18 reported products affected · est. return Jul 28, 2026Partial shortagePizotifen1 of 1 reported products affected · est. return Jul 31, 2026Partial shortageRizatriptan9 of 37 reported products affected · est. return Dec 31, 2026Partial shortageZolmitriptan11 of 28 reported products affected · est. return Jan 3, 2028No current shortageDihydroergotamine

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.